| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.26 |
3e-08 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.17 |
8e-05 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.18 |
8e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0001 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |